Search
The global medical device market was valued at $537.38 billion in 2025 and is expected to reach $826.53 billion by 2034. The integration of population aging and AI technology is reshaping the industry landscape, with minimally invasive surgery and remote monitoring becoming growth highlights.
Medical AI has moved from experimentation to clinical practice, but the practical application of diagnosis, treatment, and decision support still faces challenges in data, trust, and integration. This article reviews the current state and future trends.
According to the latest PwC report, the total value of medical technology M&A transactions in the first half of 2026 reached $36.5 billion, led by Boston Scientific's acquisition of Penumbra and Danaher's acquisition of Masimo, indicating that the industry's M&A momentum remains strong.
GE HealthCare will showcase AI software, imaging systems, radiopharmaceuticals, and localized production solutions related to nuclear medicine during SNMMI 2026, reflecting that nuclear medicine is moving from competition among single devices toward a phase of expansion driven by “platformization + ecosystemization.”